Skip Ribbon Commands
Skip to main content

Why working at PHO is important to me:

"Public Health Ontario has grown and evolved into one of this country’s public health leaders and allows for me to contribute credible scientific and technical advice to help advance public health immunization research and practice across the province. I feel fortunate to be a part of a centre of expertise dedicated to protecting and promoting the health of all Ontarians through the application and advancement of science and knowledge."

Shelley Deeks, Interim Chief, Communicable Diseases, Emergency Preparedness and Response
New: Scientist Profile
 
 
Watch Dr. Shelley Deeks talk about:
  • What excites her about her work
  • The impact of her research
  • Why she chose PHO

Trouble viewing? Watch on YouTube.

 

Appointments

Academic degrees and accreditations

  • Doctor of medicine, University of Toronto
  • Master of health sciences (Community Health and Epidemiology), University of Toronto
  • Fellow,  The Royal College of Physicians of Canada (FRCPC)
  • Fellow, Australian Faculty of Public Health Medicine (FAFPHM)

Areas of expertise

  • Communicable disease control and outbreak investigations
  • Vaccine safety
  • Epidemiology and program evaluation
  • Public Health
  • Human papillomavirus vaccine

PHO research interests

  • Applied public health research specifically with a focus on immunization and vaccine-preventable diseases (VPD), disease control and outbreak management, and vaccine program evaluation.
  • Participation in the Canadian Immunization Research Network.

Current PHO research activities

  • Providing medical and scientific leadership and support on the development, research, and evaluation of vaccine and immunization programs across Ontario.
  • Investigating the impact of rotavirus immunization on acute gastroenteritis in Ontario.
  • Involvement in studies with the Special Immunization Clinic and Provincial Collaborative Networks of the Canadian Immunization Research Network.
  • Use of passive vaccine safety surveillance data to assess vaccine safety in Ontario.
  • Providing scientific and technical advice in the area of outbreak investigation.

Top publications

  1. Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, Fediurek J, Sander B, Mazzulli T, Schulz H, Deeks SL. Measles outbreak with unique virus Genotyping, Ontario, Canada, 2015. Emerg Infect Dis. 2017;23(7):1063-9.

  2. Hawken S, Ducharme R, Rosella LC, Benchimol EI, Langley JM, Wilson K, Crowcroft NS, Halperin SA, Desai S, Naus M, Sanford CJ, Mahmud SM, Deeks SL. Assessing the risk of intussusception and rotavirus vaccine safety in Canada. Hum Vaccin Immunother. 2017;13(3):703-10.

  3. Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): a population-based assessment. Vaccine. 2016;34(39):4678-83.

  4. Wilson SE, Rosella LC, Wang J, Le Saux N, Crowcroft NS, Harris T, Bolotin S, Deeks SL. Population-level impact of Ontario's infant rotavirus immunization program: evidence of direct and indirect effects. PLoS One. 2016;11(5):e0154340.

  5. Wormsbecker AE, Wang J, Rosella LC, Kwong JC, Seo CY, Crowcroft NS, Deeks SL. Twenty years of medically-attended pediatric varicella and herpes zoster in Ontario, Canada: a population-based study. PLoS One. 2015;10(7):e0129483. Erratum in: PLoS One. 2015;10(9):e0138397.

Other publications

  1. Advisory Committee Statement: National Advisory Committee on Immunization (NACI). Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule. Public Health Agency of Canada.

  2. Vaccine Safety: Annual report on Vaccine Safety in Ontario, 2014

 

View more researchers »

Page last reviewed:  
Page last updated: 18/08/2017 11:07 AM
Uncontrolled print copy. Valid only on day of Print: [date]
Page updated on [date/time] 18/08/2017 11:07 AM
© , Ontario Agency for Health Protection and Promotion